To validate our findings, we further validated two targets, BIRC5 and DDX21, and confirmed their significant downregulation in both HCT116 and HT-29 CRC cell lines upon forced miR-218-5p expression (Figure 6A). The gene discussed is BIRC5; the disease is colorectal carcinoma.